Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Editas Medicine, Inc.Editas Medicine Reports $160.1 Million Net Loss for 2025, Revenue Increases to $40.5 Million
Amplify Energy Corp.Amplify Energy Corp. Reports $44M Net Income and Strategic Divestitures for Fiscal Year 2025
GREENLIGHT CAPITAL RE, LTD.Greenlight Capital Re Reports 74.8% Increase in Net Income for Fiscal Year 2025
Oyster Enterprises II Acquisition CorpOyster Enterprises II Acquisition Corp Reports $5.8M Net Income for Fiscal Year 2025
HERITAGE COMMERCE CORPHeritage Commerce Corp Reports 18% Increase in Net Income and Announces Merger with CVB Financial Corp
CASEYS GENERAL STORES INCCasey’s General Stores Reports Revenue Increase to $3.92 Billion and 49.3% Rise in Net Income for Q3 Fiscal 2026
FreightCar America, Inc.FreightCar America Reports $501M Revenue Decline, Net Income Turnaround in 2025
FIGX Capital Acquisition Corp.FIGX Capital Acquisition Corp. Reports $2.5 Million Net Income for Fiscal Year Ending December 31, 2025
Owlet, Inc.Owlet Reports $39.7 Million Net Loss for 2025, Achieves Positive Adjusted EBITDA
ORASURE TECHNOLOGIES INCOraSure Technologies Reports 38% Revenue Decline and $68.7 Million Net Loss for Fiscal Year 2025
NET Power Inc.NET Power Inc. Reports $578.6 Million Net Loss and Strategic Shift to Clean Gas Technology
ACCO BRANDS CorpACCO Brands Reports 8.5% Decline in Net Sales for Fiscal Year 2025
ZEVRA THERAPEUTICS, INC.Zevra Therapeutics Reports $83.2 Million Net Income and Revenue Growth in 2025
Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Reports $78.5 Million Net Loss and Advances Clinical Pipeline in 2025
Repay Holdings CorpRepay Holdings Reports $309.3 Million Revenue with Increased Net Loss in 2025
Anixa Biosciences IncAnixa Biosciences Reports No Revenue, Decreases Net Loss to $2.585 Million
MYOMO, INC.Myomo Reports 26% Revenue Growth to $40.9 Million Despite Increased Net Loss
Vicarious Surgical Inc.Vicarious Surgical Faces Financial Challenges and Delisting from NYSE
KRONOS WORLDWIDE INCKronos Worldwide Reports $110.9 Million Net Loss for Fiscal Year 2025
MACROGENICS INCMacroGenics Reports $149.5 Million Revenue for Fiscal Year 2025, Net Loss Increases to $74.6 Million
Septerna, Inc.Septerna Reports $48.9 Million Net Loss and $45.95 Million Revenue for 2025
BOX INCBox, Inc. Reports $1.18 Billion Revenue with 8% Growth for Fiscal Year Ending January 31, 2026
Castellum, Inc.Castellum, Inc. Reports 18.1% Revenue Growth to $52.9 Million for Fiscal Year 2025
VAIL RESORTS INCVail Resorts Reports Q2 Fiscal 2026 Results with $210M Net Income and Revenue Decline
Design Therapeutics, Inc.Design Therapeutics Reports $69.8 Million Net Loss for 2025, Increases R&D Spending